Rosiglitazone (BRL-49653)
Oka, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 9): 438-441
2002
ISSN/ISBN: 0047-1852 PMID: 12387030 Document Number: 542747
Document emailed within 1 workday
Related Documents
Krall, R.L. 2007: Rosiglitazone and the FDA New England Journal of Medicine 357(17): 1776-1777; Author Reply 1777Taéron, C. 2006: Rosiglitazone Revue de l'Infirmiere 118: 33-34
Scheen, A.J.; De Flines, J.; Paquot, N. 2007: What about the controversy regarding rosiglitazone Revue Medicale de Liege 62(9): 560-565
Drzewoski, J.óz.; Grzeszczak, W.ła.ła. 2007: Rosiglitazone--under fire Kardiologia Polska 65(7): 831-835
Yonezawa, N.; Oka, Y. 2001: Rosiglitazone(BRL-49653) Nihon Rinsho. Japanese Journal of Clinical Medicine 59(11): 2195-2199
Scheen, A.J. 2010: Suspension of the commercialization of sibutramine and rosiglitazone in Europe Revue Medicale de Liege 65(10): 574-579
Viberti, G.C. 2003: Rosiglitazone: potential beneficial impact on cardiovascular disease International Journal of Clinical Practice 57(2): 128-134
Bao, Z.-j.; Xiang, X.-d.; Deng, J.-w. 2003: Influence of rosiglitazone on the airway inflammation in guinea pigs with asthma Hunan Yi Ke da Xue Xue Bao 28(4): 424-426; 436
2002: Rosiglitazone and pioglitazone: new preparations. Two new oral antidiabetics both poorly assessed Prescrire International 11(62): 170-176
Cox, S.L. 2004: Rosiglitazone maleate/metformin hydrochloride: a new formulation therapy for type 2 diabetes Drugs of Today 40(7): 633-643
Chen, X.-p.; Yang, W.-y.; Bu, S.; Xiao, J.-z.; Liu, X.-l.; Wang, N.; Zhao, W.-h. 2004: Effects of rosiglitazone and metformin on insulin resistance in high-fat diet rats Zhonghua Nei Ke Za Zhi 43(4): 280-283
Wang, Z-hui.; Luo, F.; Liu, X-mei. 2005: Effect of PPARgamma agonist rosiglitazone on regression of the atherosclerotic plaques in rabbits Yao Xue Xue Bao 40(11): 1051-1053
Trivedi, H.; Lu, N.; Andresen, B.T.; Whaley-Connell, A. 2009: Slower decline of renal function after initiation of rosiglitazone in diabetics -- a pilot study Clinical Nephrology 72(3): 181-185
Wang, X.; Yang, W.-y.; Xiao, J.-z.; Zhao, W.-h.; Wang, N.; Liu, X.-l.; Pan, L. 2005: The effect of high fat feeding and rosiglitazone intervention on pancreatic alpha cell in rats Zhonghua Nei Ke Za Zhi 44(8): 601-605
Bellot-Rojas, P.; Posadas-Sanchez, R.; Caracas-Portilla, N.; Zamora-Gonzalez, J.; Cardoso-Saldaña, G.; Jurado-Santacruz, F.; Posadas-Romero, C. 2006: Comparison of metformin versus rosiglitazone in patients with Acanthosis nigricans: a pilot study Journal of Drugs in Dermatology: Jdd 5(9): 884-889
Cox, P.J.; Ryan, D.A.; Hollis, F.J.; Harris, A.M.; Miller, A.K.; Vousden, M.; Cowley, H. 2000: Absorption, disposition, and metabolism of rosiglitazone, a potent thiazolidinedione insulin sensitizer, in humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(7): 772-780
Yildirim, S.; Sundler, F.; Bolkent, S. 2007: Ghrelin and insulin gene expression changes in streptozotocin-induced diabetic rats after rosiglitazone pretreatment European Journal of Histochemistry: Ejh 51(1): 11-18
Wittayalertpanya, S.; Chompootaweep, S.; Thaworn, N.; Khemsri, W.; Intanil, N. 2010: Pharmacokinetic and bioequivalence study of an oral 8 mg dose of rosiglitazone tablets in Thai healthy volunteers Journal of the Medical Association of Thailand 93(6): 722-728
Veneman, T.F. 2007: The pharmacological prevention and treatment of diabetes mellitus; significance of 2 recent, large studies for the use of rosiglitazone Nederlands Tijdschrift Voor Geneeskunde 151(9): 514-516
Flores-Saenz, J.L.; Trujillo-Arriaga, H.M.; Rivas-Vilchis, J.F.; Mendez-Francisco, J.D.; Alarcon-Aguilar, F.J.; Roman-Ramos, R. 2003: Crossover and double blind study with metformin and rosiglitazone in impaired glucose tolerance subjects Proceedings of the Western Pharmacology Society 46: 143-147